Mounjaro side effects: what to expect
Published 19 May 2026 · Updated 9 July 2026
The most common Mounjaro side effects are digestive: nausea, diarrhoea, constipation and vomiting. In the main weight management trial, nausea affected 24% to 33% of participants depending on dose, most cases were mild to moderate, and they clustered around dose increases rather than running through the whole treatment.
Context matters when weighing this up. The same trial recorded average weight loss of 15% to 21% of body weight over 72 weeks, and individual results vary. Side effects are the cost side of that ledger, and for a small group they are reason enough to stop.
This guide covers what is common, what is rare but serious, who should not use the medicine at all, and how side effects are handled in South African care.
What are the most common Mounjaro side effects?
Digestive effects dominate, which follows from how tirzepatide works: it slows stomach emptying and changes appetite signalling. The SURMOUNT-1 trial, which followed 2,539 adults for 72 weeks, measured them by dose.
| Side effect | How many affected in SURMOUNT-1 | Typical pattern |
|---|---|---|
| Nausea | 24% to 33% | Worst in the days after a dose increase |
| Diarrhoea | 17% to 23% | Episodic, usually short-lived |
| Constipation | 11% to 17% | Builds gradually, responds to fibre and fluids |
| Vomiting | 6% to 13% | Less common, linked to large or fatty meals |
Indigestion, burping, reflux, reduced appetite, fatigue and injection-site redness also appear on the label as common effects. Placebo groups reported many of the same complaints at lower rates, which is worth remembering before blaming the pen for everything.
When do Mounjaro side effects start and how long do they last?
The pattern is predictable: effects peak in the first weeks on a new dose, then fade as the body adjusts. Each step up the dose ladder can restart a milder version of the same cycle, which is why the first month on any new strength is the stretch to watch.
A pooled analysis of the four SURMOUNT trials found most digestive effects were non-serious and transient. Stopping treatment because of them was the exception, not the rule: in SURMOUNT-1, well under one in ten participants stopped for adverse events, though that is still a real outcome for some. Individual results vary.
Side effects that persist for weeks without easing, or that get worse instead of better after a dose increase, break the expected pattern. That is a signal to contact your doctor rather than wait for the next review.
What increases the risk of side effects?
Speed, mostly. Climbing the dose ladder faster than the gut adapts is the single most reliable way to feel worse, which is why the registered schedule holds each dose for at least four weeks and why doctors often go slower.
Meals do their share. Large portions, fried and fatty food, and alcohol all sit badly on a stomach that is emptying more slowly than it used to. Skipping fluids raises the stakes of any vomiting or diarrhoea that does happen.
Your starting point counts as well. A history of reflux, irritable bowel or gallstones makes digestive effects more likely, and combining tirzepatide with insulin or sulfonylureas changes the low blood sugar risk entirely. All of it is manageable, but only if the doctor knows about it upfront.
How do you manage Mounjaro side effects?
Most of the digestive effects respond to eating adjustments. Smaller portions, slower eating, less fat and less alcohol reduce nausea. Steady water intake through the day protects against the dehydration that diarrhoea and vomiting can cause. For constipation, fibre and fluids come first, with a pharmacist-recommended laxative as the backup if a few days pass without relief.
Timing the weekly injection can help too. Some people find side effects easier to absorb when injection day lands before a quiet stretch, a Friday evening rather than the night before a heavy work day. The day itself is flexible as long as doses stay roughly seven days apart; confirm any change with your doctor.
Dose pacing is the other lever. There is no obligation to climb to the next strength on schedule; doctors routinely hold a dose for extra weeks until the gut settles. The schedule and its flexibility are covered in our Mounjaro dosage guide.
Food choices deserve their own planning; see what to eat on GLP-1 medication. And since the digestive playbook is shared across this class of medicine, managing GLP-1 side effects goes deeper on remedies and timing.
Which Mounjaro side effects are serious?
Rare, but they need naming. Pancreatitis is the headline risk: severe, persistent stomach pain, sometimes radiating to the back, with or without vomiting. If that happens, stop injecting and seek medical care immediately.
Gallbladder problems occurred in 1.1% of trial participants against 0.4% on placebo; pain under the right ribs, fever or yellowing skin needs prompt medical attention. Severe dehydration from ongoing vomiting or diarrhoea can strain the kidneys, so persistent fluid loss is not something to ride out at home. Serious allergic reactions, with swelling of the face or throat or difficulty breathing, mean emergency care.
Tirzepatide caused thyroid C-cell tumours in rodent studies. Whether that translates to humans is unknown, and the SAHPRA-approved information carries the warning; a new lump in the neck, hoarseness or trouble swallowing should be examined. Low blood sugar is uncommon with tirzepatide alone but becomes a real risk when it is combined with insulin or sulfonylurea diabetes medicine.
Who should not use Mounjaro?
Some exclusions are absolute. Mounjaro is not used during pregnancy or breastfeeding, by anyone planning pregnancy in the near term, or by people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. A previous serious allergic reaction to tirzepatide rules it out, and it is not registered for anyone under 18.
Other histories call for judgement rather than automatic exclusion: past pancreatitis, significant gut disease such as gastroparesis, severe kidney problems and diabetic eye disease all belong in the assessment conversation.
One practical note from the label for women using oral contraceptives: because the medicine slows stomach emptying, a barrier method is advised for four weeks after starting and after each dose increase.
Do side effects mean the medicine is working?
No. Nausea is not a progress report. Weight loss in the trials tracked dose and time on treatment, not how sick anyone felt, and plenty of participants lost significant weight with no digestive complaints at all. Individual results vary.
The reverse is also true: feeling fine does not mean the dose is too low. Judging by symptoms leads people to push doses up chasing discomfort or panic when side effects fade, and both instincts point the wrong way. The scale, the tape measure and your doctor's reviews measure progress; side effects only measure adjustment.
Mounjaro side effects in South Africa: monitoring and reporting
The South African label matches the international evidence, and SAHPRA registered the medicine with the same warnings described above. Registration details and availability are covered in is Mounjaro available in South Africa.
Side effects are also why treatment here is structured around follow-up. A doctor reviews progress before each dose change, which is exactly where most problems surface and get solved. What those reviews look like in a doctor-led programme is described in what to expect.
South Africans can report suspected side effects directly to SAHPRA through its Med Safety app or reporting forms, alongside telling their doctor and pharmacist. Reports feed the safety monitoring that keeps the label current.
Frequently asked questions
Do Mounjaro side effects go away?
For most people, yes. Digestive effects peak in the first weeks on a new dose and fade as the body adjusts, though each dose increase can briefly bring them back.
Does Mounjaro make you tired?
Fatigue is a recognised common side effect, especially early on and when eating much less. It usually passes; tiredness that persists is worth raising with your doctor.
Does Mounjaro cause hair loss?
Around 5% of participants in tirzepatide weight management trials reported hair loss, against about 1% on placebo. It is linked mainly to rapid weight loss itself and usually recovers over time.
Can Mounjaro cause low blood sugar?
Rarely on its own. The risk rises meaningfully when it is combined with insulin or sulfonylurea diabetes medicine, which is why a doctor reviews everything you take first.
Is Mounjaro safe to use long term?
Trial follow-up extending to three years has not shown new safety signals, and regulators continue monitoring. Long-term use should stay under regular medical review.
What should you do about severe stomach pain on Mounjaro?
Treat it as urgent. Severe, persistent pain, especially radiating to the back, can signal pancreatitis: stop injecting and seek medical care immediately.
Sources
This article is general information, not personal medical advice. Treatment decisions are made by a registered doctor on assessment. Individual results vary.